Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Sanofi's new logo

Sanofi name change sees Aventis dropped

May 9, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Sanofi-Aventis

Sanofi-Aventis will now just be known as Sanofi after the French pharma company’s shareholders agreed to change its name. Following …
News

Thomas Lingelbach appointed chief executive of Intercell

May 5, 2011 Research and Development appointment, research and development

Vienna-based biotech Intercell has appointed Thomas Lingelbach as chief executive with effect from 10 May. He has more than twenty …
Appointment

INC Research to acquire Kendle

May 5, 2011 Research and Development INC Research, Kendle, cros

Two contract research organisations INC Research and Kendle International are to merge to create a new major player in the …
News

Sanofi signs malaria research alliance

May 5, 2011 Research and Development Medicines for Malaria Venture, Sanofi-Aventis, malaria

Sanofi-Aventis has signed a research deal with the Medicines for Malaria Venture charity. They will work together to identify, characterise …
News

Debiopharm and Yale University to develop autoimmune treatment

May 5, 2011 Research and Development Debiopharm, Yale University

Debiopharm is teaming up with researchers at Yale University to develop Debio 1036, a first-in-class inhibitor for autoimmune and inflammatory …
News
Roche's Avastin (bevacizumab)

Avastin as effective as Lucentis in eye disease

May 4, 2011 Research and Development Lucentis, avastin, off label, wet AMD

Roche’s cancer drug Avastin is as effective at treating wet AMD as Novartis’ Lucentis, which is licensed for the eye …
News

Service Insight: Due diligence in emerging markets for clinical development

May 4, 2011 Research and Development Service Insight, Talking Point, research and development

SERVICE INSIGHT Currently, the pharma industry is experiencing an unprecedented wave of blockbuster drug patent expiries. There is a lack …
Feature

Contract research news in brief

May 4, 2011 Research and Development contract research, cros, research and development

This week’s CRO news roundup includes Omnicare CR and LAB Research changing hands, Q1 financials for ICON and PPD and …
News

Astellas adds senior executives to global development team

May 4, 2011 Research and Development appointment, research and development

Astellas Pharma has made four new senior appointments to its US-based global development team. Former Eli Lilly vice president of …
Appointment
Cephalon

Cephalon accepts Teva’s $6.8 billion white knight bid

May 3, 2011 Research and Development, Sales and Marketing Cephalon, Teva, Valeant, generics

Generics giant Teva has acquired Cephalon for $6.8 billion and says the deal will make it a leading specialty pharmaceutical …
News
Boehringer Ingelheim

Boehringer begins late-stage hep C trial

April 27, 2011 Research and Development BI 201335, Boehringer Ingelheim, hepatitis C

Boehringer Ingelheim has begun enrolling patients in North America for a phase III trial of its chronic hepatitis C virus …
News
Pfizer

Deaths reported in Pfizer arthritis trial

April 26, 2011 Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Four deaths have been reported in a late-stage study of Pfizer’s arthritis drug tofacitinib. Three of the deaths are thought …
News

Sten Westerberg joins BioInvent

April 26, 2011 Research and Development appointment, research and development, sales and marketing

Swedish pharma company BioInvent International has appointed Sten Westerberg to the newly-created position of vice president investor relations. Sten is …
Appointment

UCB and Amgen’s osteoporosis drug shows promise

April 21, 2011 Research and Development Amgen, UCB, osteoporosis

Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …
News

Trevor Smith to lead Takeda in Europe

April 21, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …
Appointment
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026